January 2016
 
 C'est un vrai plaisir de vous souhaiter une excellente année 2016 de la part de toute l'équipe HCS Pharma. 2015 fut intense pour nous avec le développement de nos modèles cellulaires et la consolidation de nos outils numériques. 2016 va s'ouvrir sur un nouveau challenge avec notre entrée dans le bioincubateur d'Eurasanté et l'ouverture d'une structure sur Lille. Vous voulez en savoir plus ? Contactez-nous !

 It's a real pleasure to wish you a great year 2016 from the whole HCS Pharma's team. 2015 was intense for us with the development of cellular models and the improvement of our digital process. 2016 will open a new challenge with the entry in Eurasanté bioincubator and the opening of a second location in Lille. Want to know more ? Contact us ! 
We are pleased to announce that our incubation request in the Bioincubator of Eurasanté in Lille has been accepted in December 2015. The year 2016 will be exciting and fertile for HCS Pharma with the installation of a second location in Lille.
 

Open innovation to sharing the risk

The pharmaceutical industry is in upheaval. Since 20 years, inefficiency of pharmaceutical industry to turn its discoveries into new drugs force them to change their model. After target-based screening, they come back to phenotypic screening by high content screening and by using more relevant models as 3D cell models. 

High Content & Phenotypic Screening event

Phenotypic screening was the primary mechanism of drug discovery for decades before the development of genomics enabled target selection, so this revival of interest in phenotypic screening is really a return to the past. …But of the 50 first-in-class new molecular entities (NMEs) approved for clinical use, 28 (56%) were discovered using a phenotypic approach, while 17 (34%) were target-based discoveries.

organ-on-a-chip / body-on-a-chip, a way for personalized medecine ?

Since few years, the technology is more and more used to finaly create organ-on-a-chip and now body-on-chip with different organs. More and more academical units and collaborative projects allowed to succed to miniaturise different organs in different chambers on a chip connected with microfluidy. 

We win the innovation prize at "Femmes de l'économie Grand Ouest 2015


Our CEO, Nathalie, participated last month at the 2015 edition of the "Femmes de l'économie" contest for the west of France. We are happy to announce that she won the innovation technology prize. We prepare now the national contest, which taking place at the end of november at the french national assembly in Paris.

Services

Explain us your requirements and we develop your assays to best meet your needs !

Our vision

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

View this email in your browser
Website
Website
LinkedIn
LinkedIn
Twitter
Twitter
Google Plus
Google Plus
Contact Us
Contact Us
Copyright © 2016 HCS Pharma, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp